Medicare Enrolled
Dr. John Lee, M.D.
Family Medicine · New Braunfels, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. John Lee is a family medicine specialist in New Braunfels, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 2,051 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lee received a total of $8,100 from 48 pharmaceutical and/or device companies across 489 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 13% volume in TX
$8,100 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,051
Medicare services
Top 13% in TX for family medicine
Not available
Unique patients (not deduplicated)
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,106 | $86 | $124 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
392 | $62 | $88 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
69 | $10 | $14 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
64 | $5 | $7 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
56 | $2 | $3 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
47 | $1 | $1 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
40 | $16 | $28 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
36 | $12 | $13 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
35 | $41 | $45 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $39 | $55 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
32 | $61 | $77 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
30 | $150 | $199 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
28 | $62 | $81 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $106 | $162 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $100 | $127 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
16 | $6 | $28 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
11 | $5 | $28 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,100
Total received (2018-2024)
Avg $1,157/year across 7 years
Top 7% in TX for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
489
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$852
2023
$948
2022
$1,083
2021
$1,330
2020
$370
2019
$1,971
2018
$1,545
Payments by company (2024)
Novo Nordisk Inc
$186
Lilly USA, LLC
$184
GlaxoSmithKline, LLC.
$151
PFIZER INC.
$96
ABBVIE INC.
$77
AstraZeneca Pharmaceuticals LP
$40
Bayer Healthcare Pharmaceuticals Inc.
$35
ALK-Abello, Inc
$27
Abbott Laboratories
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Amgen Inc.
$16
Top 3 companies account for 61.3% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$863
Novo Nordisk Inc
$836
GlaxoSmithKline, LLC.
$628
Amarin Pharma Inc.
$626
AstraZeneca Pharmaceuticals LP
$496
Boehringer Ingelheim Pharmaceuticals, Inc.
$447
ABBVIE INC.
$427
Amgen Inc.
$341
Takeda Pharmaceuticals U.S.A., Inc.
$312
AbbVie Inc.
$266
SANOFI-AVENTIS U.S. LLC
$239
AbbVie, Inc.
$230
Janssen Pharmaceuticals, Inc
$211
Merck Sharp & Dohme Corporation
$208
PFIZER INC.
$177
Abbott Laboratories
$165
Antares Pharma, Inc.
$145
Shire North American Group Inc
$144
IDORSIA PHARMACEUTICALS US INC
$136
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$114
Allergan Inc.
$105
Astellas Pharma US Inc
$105
Kowa Pharmaceuticals America, Inc.
$90
Genentech USA, Inc.
$82
Radius Health, Inc.
$72
Intuitive Surgical, Inc.
$72
Novartis Pharmaceuticals Corporation
$59
SANOFI PASTEUR INC.
$41
Sanofi Pasteur Inc.
$40
Merck Sharp & Dohme LLC
$38
Daiichi Sankyo Inc.
$35
Bayer Healthcare Pharmaceuticals Inc.
$35
Medicure Pharma Inc.
$29
Mannkind Corporation
$29
ALK-Abello, Inc
$27
Eisai Inc.
$25
Allergan, Inc.
$22
ARBOR PHARMACEUTICALS, INC.
$21
Corcept Therapeutics
$21
Bayer HealthCare Pharmaceuticals Inc.
$20
Sunovion Pharmaceuticals Inc.
$20
Mylan Specialty L.P.
$19
Esperion Therapeutics, Inc.
$16
IBSA Pharma Inc.
$15
Biohaven Pharmaceuticals, Inc.
$14
E.R. Squibb & Sons, L.L.C.
$14
Corium, LLC
$13
Noden Pharma USA Inc
$12
Top 3 companies account for 28.7% of all-time payments
Associated products mentioned in payments ›
ADLARITY · AFREZZA · AIRSUPRA · ANORO · AVYCAZ · Aimovig · Amitiza · Androgel · BELSOMRA · BEXSERO · BREO · BREZTRI · BYDUREON · BYSTOLIC · Da Vinci Surgical System · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FORTEO · FREESTYLE LIBRE 3 · GARDASIL 9 · Grastek · HeartMate · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LINZESS · LOKELMA · LONHALA MAGNAIR · Livalo · MAVYRET · MENACTRA · MOUNJARO · MOVANTIK · MYDAYIS · MYRBETRIQ · Motegrity · Myrbetriq · NEXLETOL · NO PRODUCT DISCUSSED · NOCDURNA · NURTEC ODT · ORIAHNN · Otrexup · Ozempic · PNEUMOVAX 23 · PREMARIN · Prolia · QULIPTA · QUVIVIQ · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TEFLARO · TEKTURNA · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Welchol · XARELTO · XIFAXAN · XIGDUO · XYOSTED · Xofluza · Yupelri · Zypitamag
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
234
County median income
$93,776
Nearest hospital to ZIP centroid (approximate)
RESOLUTE HEALTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lee performed 1,106 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $8,100 from 48 companies across 489 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other family medicine physicians in New Braunfels?
Dr. Lee's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in New Braunfels
Browse family medicine physicians in New Braunfels ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology